Panel

Information on Panel composition and the Conflict of Interest Policy can be found in Methods Table 1; financial relationships between Panel members and commercial firms are listed in the Disclosure Table.

Chairs

Raymond T. Chung, MD Harvard Medical School	Susanna Naggie, MD, MHS Duke University School of Medicine Durham VA Medical Center
Arthur Y. Kim, MD Harvard Medical School	Hugo E. Vargas, MD College of Medicine, Mayo Clinic

Panel Members

Andrew I. Aronsohn, MD University of Chicago Medical Center	Timothy R. Morgan, MD Veterans Affairs Long Beach Healthcare System
Debika Bhattacharya, MD University of California Los Angeles	Ronald G. Nahass, MD, MHCM, FACP, FIDSA ID Care
Michael R. Charlton, MD Intermountain Medical Center	Marion G. Peters, MD University of California San Francisco
Oluwaseun O. Falade-Nwulia, MBBS, MPH Johns Hopkins University School of Medicine	Daniel Raymond Harm Reduction Coalition
Robert J. Fontana, MD University of Michigan Medical School	Nancy S. Reau, MD Rush University Medical Center
Eliot W. Godofsky, MD, FACP Bach and Godofsky, Infectious Diseases	K. Rajender Reddy, MD Hospital of the University of Pennsylvania
Theo Heller, MD National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health	Andrew Reynolds Project Inform
Scott D. Holmberg, MD** + National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention	Michael S. Saag, MD The University of Alabama at Birmingham
Jennifer J. Kiser, PharmD University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences	John D. Scott, MD, MSc, FIDSA Hepatitis and Liver Clinic University of Washington
Shyam Kottilil, MD, PhD Division of Infectious Diseases Institute of Human Virology/University of Maryland	Tracy Swan Treatment Action Group
Benjamin P. Linas, MD, MPH Boston University School of Medicine	Norah A. Terrault, MD University of California San Francisco
Kristen M. Marks, MD Weill Cornell Medical College	John B. Wong, MD Tufts University School of Medicine
Paul Martin, MD University of Miami School of Medicine	David L. Wyles, MD University of California San Diego

*Individual employees of the National Institutes of Health (NIH) have participated in the planning and development of the Guidance, although the NIH is not an official sponsor.

**The views expressed by the participants do not necessarily represent the opinions of the Centers for Disease Control and Prevention, the National Institutes of Health, or the Department of Health and Human Services.

+ Non-voting Panel members

Previous Panel Chairs

Gary L. Davis, MD Baylor University Medical Center (retired) 2013-2015	Michael S. Saag, MD The University of Alabama at Birmingham 2013-2015
Donald M. Jensen, MD University of Chicago Medical Center (retired) 2013-2014	David L. Thomas, MD, MPH The Johns Hopkins University School of Medicine 2013-21015
Henry Masur, MD* ** National Institutes of Health 2013-2015

Previous Panel Members

Jordan J. Feld, MD, MPH Toronto Western Hospital Liver Center 2013-2015	Robert T. Schooley, MD University of California San Diego 2013-2015
Marc G. Ghany, MD* ** National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health 2013-2015	Kenneth E. Sherman, MD, PhD University of Cincinnati College of Medicine 2013-2015
Camilla S. Graham, MD, MPH TREK Therapeutics, PBC 2014-2015	Mark S. Sulkowski, MD The Johns Hopkins University School of Medicine 2013-2015
Kiren Mitruka, MD, MPH** + National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention 2013-2015	John W. Ward, MD** + National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention 2013-2015

Contributors and Technical Advisors

Saleem Kamili, PhD** Division of Viral Hepatitis Deputy Chief, Laboratory Branch, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention For contributing to development of the Testing and Linkage to Care Table 1: FDA-approved, Commercially Available Anti-HCV Screening Assays	Judith Welsh, BS, MLS* ** Clinical Informationist NIH Library National Institutes of Health For performing comprehensive literature searches to identify the evidence used to prepare the Guidance
Rachel J. Wilson** Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention For comprehensive copy editing and styling of the final Guidance

HCV Guidance Project Management

Sheila A. Tynes, MHA

Program Director

Vincent Keane

Website Publication and Management

Acknowledgement

The International Antiviral Society–USA (IAS–USA) served as the collaborating partner for the HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C from the project’s inception in mid- 2013 through 2015. IAS-USA was responsible for managing the writing panel and the guidance development process. A representative from IAS–USA also served as a co-chair of the HCV Guidance Panel. Due to priorities related to their core mission, IAS-USA elected to end their relationship as collaborating partner on December 31. AASLD and IDSA recognize IAS-USA’s tremendous contribution to the HCV Guidance and the creation and maintenance of www.hcvguidelines.org. Special appreciation is extended to the following individuals for their outstanding service:

Michael Saag, MD
Donna Jacobsen
Cindy Downing
Michelle Valderama
Jennezel Peneda
Rachel Lastra

Panel

Chairs

Panel Members

Previous Panel Chairs

Gary L. Davis, MD

Michael S. Saag, MD

Donald M. Jensen, MD

David L. Thomas, MD, MPH

Henry Masur, MD* **

Previous Panel Members

Jordan J. Feld, MD, MPH

Robert T. Schooley, MD

Marc G. Ghany, MD* **

Kenneth E. Sherman, MD, PhD

Camilla S. Graham, MD, MPH

Mark S. Sulkowski, MD

Kiren Mitruka, MD, MPH** +

John W. Ward, MD** +

Contributors and Technical Advisors

Saleem Kamili, PhD**

Judith Welsh, BS, MLS* **

Rachel J. Wilson**

HCV Guidance Project Management

Sheila A. Tynes, MHA

Vincent Keane

Acknowledgement